Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07166341 · ClinicalTrials.gov registry record
Accuracy Verification of the INVOS PM7100
A clinical trial of Tissue Oxygenation, sponsored by Medtronic - MITG.
- Active
- Registry status
- 48
- Enrollment target
- 1
- Study location
NCT07166341 is a study of Tissue Oxygenation that is active but no longer recruiting, run by Medtronic - MITG. The registered enrollment target is 48 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07166341, a study of Tissue Oxygenation, is active but no longer recruiting, sponsored by Medtronic - MITG.
- ACTIVE NOT RECRUITING
- Registry status
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, observational, pre-market, verification study to confirm accuracy of the INVOS 7100 system in compliance with ISO 80601-2-85:2021 standard
Conditions Studied
Interventions
- DEVICE Observational
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2025-09-29 |
| Est. Completion | 2026-04-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07166341
The ClinicalTrials.gov registry entry for NCT07166341 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tissue Oxygenation appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT07166341 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT07166341 about?
NCT07166341 is a clinical study titled "Accuracy Verification of the INVOS PM7100". Prospective, observational, pre-market, verification study to confirm accuracy of the INVOS 7100 system in compliance with ISO 80601-2-85:2021 standard
What is the current status of trial NCT07166341?
This trial is currently active not recruiting. The enrollment target is 48 participants. The study started on 2025-09-29. Estimated completion is 2026-04-24.
What conditions does trial NCT07166341 study?
This clinical trial studies the following conditions: Tissue Oxygenation.
What interventions are being tested in trial NCT07166341?
The interventions under investigation include: Observational (DEVICE).
Who is sponsoring clinical trial NCT07166341?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07166341 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.